leadf
logo-loader
TSX-V:THRM OTC:TBRIF FRA:JNX

Therma Bright Inc

Receive alerts
Market:
TSX-V
Market Cap:
$92.95 m
Price
0.43 CAD
Change
-1.16%
52 weeks high
1.05
52 weeks low
0.07

In brief

Therma Bright, developer of the AcuVid™ COVID-19 Rapid Antigen Saliva Test, is a progressive medical diagnostic and device technology company focused on providing consumers and medical professionals with quality, innovative solutions that address some of today’s most important medical and healthcare challenges. The Company’s initial breakthrough proprietary technology delivers effective, non-invasive and pain-free skincare. Therma Bright received a Class II medical device status from the FDA for its platform technology that is indicated for the relief of the pain, itch, and inflammation of a variety of insect bites or stings. The Company received clearance for the above claims from the US FDA in 1997.